CoChat

In vitro and in vivo analysis of B-Myb in basal-like breast cancer

Open access
Thorner, A R, Hoadley, K A, Parker, J S, Winkel, S, Millikan, R C, Perou, C M · 2009 · Oncogene
Cited by 98

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

A defining feature of basal-like breast cancer, a breast cancer subtype with poor clinical prognosis, is the high expression of ‘proliferation signature’ genes. We identified B-Myb, a MYB family transcription factor that is often amplified and overexpressed in many tumor types, as being highly expressed in the proliferation signature. However, the roles of B-Myb in disease progression, and its mammary-specific transcriptional targets, are poorly understood. Here, we showed that B-Myb expression is a significant predictor of survival and pathological complete response to neoadjuvant chemotherapy in breast cancer patients. We also identified a significant association between the G/G genotype of a nonsynonymous B-Myb germline variant (rs2070235, S427G) and an increased risk of basal-like breast cancer [OR 2.0, 95% CI (1.1–3.8)]. In immortalized, human mammary epithelial cell lines, but not in basal-like tumor lines, cells ectopically expressing wild-type B-Myb or the S427G variant showed increased sensitivity to two DNA topoisomerase IIα inhibitors, but not to other chemotherapeutics. In addition, microarray analyses identified many G2/M genes as being induced in B-Myb overexpressing cells. These results confirm that B-Myb is involved in cell cycle control, and that its dysregulation may contribute to increased sensitivity to a specific class of chemotherapeutic agents. These data provide insight into the influence of B-Myb in human breast cancer, which is of potential clinical importance for determining disease risk and for guiding treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2008.430

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors

    Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527 · cited 1×

    “To determine whether the 217-gene SAM list was enriched for genes within a particular phase of the cell cycle, each gene was assigned to a specific phase by comparing it with a known list derived from a precise cell cycle microarray time-course experiment (Whitfield et al., 2002), or by literature search.”
    MethodSelf-citation
  • Common markers of proliferation

    Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1802 · Cited by 650 · cited 2×

    “Basal-like breast cancer has an inherently high proliferation rate, which is identified by high expression of the ‘proliferation signature’ genes through microarray analysis; this signature has been identified in many tumor types, as per several publications, and is highly enriched for cell cycle-regulated genes (Whit…”
    BackgroundSelf-citation

Show all 2 references

Cited by

See all 98

Metadata

Authors
Thorner, A. R., Hoadley, K. A., Parker, J. S., Winkel, S., Millikan, R. C., & Perou, C. M.
Venue
Oncogene
Published
2008-12-01
Volume
28
Issue
5
Pages
742-751
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2068182875
Cited by
98
References
2
FWCI
1.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro and in vivo analysis of B-Myb in basal-like breast cancer. https://app.cochat.ai/papers/10.1038/onc.2008.430
The paper
Thorner, A. R., Hoadley, K. A., Parker, J. S., Winkel, S., Millikan, R. C., & Perou, C. M. (2009). In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene. https://doi.org/10.1038/onc.2008.430

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.